ReviewThe Journal of clinical investigation2023

Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments.

Luc Leybaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.